HEADER PEPTIDE BINDING PROTEIN 25-JUN-16 5GIY TITLE HSA-PALMITIC ACID-[RUCL5(IND)]2- COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERUM ALBUMIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 27-607; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ALB; SOURCE 6 EXPRESSION_SYSTEM: PICHIA KUDRIAVZEVII; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4909 KEYWDS HUMAN SERUM ALBUMIN, RUTHENIUM-BASED DRUGS, DRUG DELIVERY SYSTEMS, KEYWDS 2 INTERACTIONS OF PROTEIN-LIGAND, ANTICANCER ACTIVITY, PEPTIDE BINDING KEYWDS 3 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR F.YANG,T.WANG REVDAT 2 08-NOV-23 5GIY 1 REMARK REVDAT 1 19-JUL-17 5GIY 0 JRNL AUTH F.YANG,T.WANG JRNL TITL STRUCTURE OF HSA-PALMITIC ACID-[RUCL5(IND)]2- JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH Y.ZHANG,A.HO,J.YUE,L.KONG,Z.ZHOU,X.WU,F.YANG,H.LIANG REMARK 1 TITL STRUCTURAL BASIS AND ANTICANCER PROPERTIES OF REMARK 1 TITL 2 RUTHENIUM-BASED DRUG COMPLEXED WITH HUMAN SERUM ALBUMIN REMARK 1 REF EUROPEAN JOURNAL OF V. 86 449 2014 REMARK 1 REF 2 MEDICINAL CHEMISTRY REMARK 1 REFN ISSN 0223-5234 REMARK 2 REMARK 2 RESOLUTION. 2.54 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.54 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.43 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 22025 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.227 REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.279 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.130 REMARK 3 FREE R VALUE TEST SET COUNT : 1129 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.4364 - 5.0847 0.97 2682 157 0.1791 0.2446 REMARK 3 2 5.0847 - 4.0366 1.00 2630 165 0.1915 0.2447 REMARK 3 3 4.0366 - 3.5266 1.00 2628 136 0.2367 0.2931 REMARK 3 4 3.5266 - 3.2042 1.00 2635 137 0.2676 0.3181 REMARK 3 5 3.2042 - 2.9746 1.00 2616 127 0.3021 0.3656 REMARK 3 6 2.9746 - 2.7993 1.00 2614 141 0.3028 0.3605 REMARK 3 7 2.7993 - 2.6591 1.00 2627 143 0.2985 0.3479 REMARK 3 8 2.6591 - 2.5433 0.94 2464 123 0.3036 0.3474 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.390 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.450 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 4844 REMARK 3 ANGLE : 0.523 6480 REMARK 3 CHIRALITY : 0.020 707 REMARK 3 PLANARITY : 0.002 834 REMARK 3 DIHEDRAL : 12.100 1859 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' REMARK 3 ORIGIN FOR THE GROUP (A): 24.9409 -0.2294 19.9609 REMARK 3 T TENSOR REMARK 3 T11: 0.5928 T22: 0.3091 REMARK 3 T33: 0.6120 T12: 0.0319 REMARK 3 T13: 0.0532 T23: 0.0517 REMARK 3 L TENSOR REMARK 3 L11: 1.6701 L22: -0.0100 REMARK 3 L33: 1.2622 L12: 0.0320 REMARK 3 L13: 0.1968 L23: 0.3225 REMARK 3 S TENSOR REMARK 3 S11: 0.1257 S12: -0.0167 S13: -0.0306 REMARK 3 S21: 0.0398 S22: -0.0513 S23: -0.0137 REMARK 3 S31: -0.1573 S32: -0.1980 S33: -0.0027 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5GIY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 14-JUL-16. REMARK 100 THE DEPOSITION ID IS D_1300000853. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : NONIUS KAPPA CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22025 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 47.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 1BJ5 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 28 PEG3350, 6% GLYCEROL, 4% DMSO., PH REMARK 280 7.0, EVAPORATION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 92.92250 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.35500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 92.92250 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 19.35500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 41 CG CD CE NZ REMARK 470 LYS A 181 CE NZ REMARK 470 ARG A 186 CZ NH1 NH2 REMARK 470 LYS A 240 CD CE NZ REMARK 470 LYS A 389 CG CD CE NZ REMARK 470 GLU A 396 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR A 401 O2 PLM A 1005 1.25 REMARK 500 OG SER A 489 O2 PLM A 1004 1.27 REMARK 500 OG SER A 287 O2 PLM A 1002 1.28 REMARK 500 CE1 HIS A 146 N06 7GE A 1007 1.87 REMARK 500 NE2 HIS A 146 N06 7GE A 1007 1.99 REMARK 500 CZ TYR A 401 O2 PLM A 1005 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 147 C - N - CA ANGL. DEV. = 10.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 30 -60.03 -90.92 REMARK 500 PRO A 110 -173.57 -69.84 REMARK 500 ASP A 173 77.82 -103.33 REMARK 500 ASN A 267 40.94 -107.84 REMARK 500 LYS A 274 46.16 -83.78 REMARK 500 PRO A 303 -172.75 -68.07 REMARK 500 VAL A 310 -67.43 -136.62 REMARK 500 ALA A 322 88.00 -167.03 REMARK 500 VAL A 469 -32.55 -141.94 REMARK 500 LEU A 481 3.98 -68.66 REMARK 500 LYS A 564 -51.46 -124.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 PLM A 1001 REMARK 610 PLM A 1003 REMARK 610 PLM A 1005 REMARK 610 7GE A 1008 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 7GE A1007 RU2 REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 146 NE2 REMARK 620 2 7GE A1007 N06 60.0 REMARK 620 3 7GE A1007 CL5 81.5 138.2 REMARK 620 4 7GE A1007 CL3 161.5 109.7 111.7 REMARK 620 5 7GE A1007 CL4 58.2 86.1 86.9 108.1 REMARK 620 6 7GE A1007 CL1 89.1 78.3 85.9 104.2 147.2 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PLM A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PLM A 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PLM A 1003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PLM A 1004 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PLM A 1005 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PLM A 1006 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7GE A 1007 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7GE A 1008 DBREF 5GIY A 3 583 UNP P02768 ALBU_HUMAN 27 607 SEQRES 1 A 581 HIS LYS SER GLU VAL ALA HIS ARG PHE LYS ASP LEU GLY SEQRES 2 A 581 GLU GLU ASN PHE LYS ALA LEU VAL LEU ILE ALA PHE ALA SEQRES 3 A 581 GLN TYR LEU GLN GLN CYS PRO PHE GLU ASP HIS VAL LYS SEQRES 4 A 581 LEU VAL ASN GLU VAL THR GLU PHE ALA LYS THR CYS VAL SEQRES 5 A 581 ALA ASP GLU SER ALA GLU ASN CYS ASP LYS SER LEU HIS SEQRES 6 A 581 THR LEU PHE GLY ASP LYS LEU CYS THR VAL ALA THR LEU SEQRES 7 A 581 ARG GLU THR TYR GLY GLU MET ALA ASP CYS CYS ALA LYS SEQRES 8 A 581 GLN GLU PRO GLU ARG ASN GLU CYS PHE LEU GLN HIS LYS SEQRES 9 A 581 ASP ASP ASN PRO ASN LEU PRO ARG LEU VAL ARG PRO GLU SEQRES 10 A 581 VAL ASP VAL MET CYS THR ALA PHE HIS ASP ASN GLU GLU SEQRES 11 A 581 THR PHE LEU LYS LYS TYR LEU TYR GLU ILE ALA ARG ARG SEQRES 12 A 581 HIS PRO TYR PHE TYR ALA PRO GLU LEU LEU PHE PHE ALA SEQRES 13 A 581 LYS ARG TYR LYS ALA ALA PHE THR GLU CYS CYS GLN ALA SEQRES 14 A 581 ALA ASP LYS ALA ALA CYS LEU LEU PRO LYS LEU ASP GLU SEQRES 15 A 581 LEU ARG ASP GLU GLY LYS ALA SER SER ALA LYS GLN ARG SEQRES 16 A 581 LEU LYS CYS ALA SER LEU GLN LYS PHE GLY GLU ARG ALA SEQRES 17 A 581 PHE LYS ALA TRP ALA VAL ALA ARG LEU SER GLN ARG PHE SEQRES 18 A 581 PRO LYS ALA GLU PHE ALA GLU VAL SER LYS LEU VAL THR SEQRES 19 A 581 ASP LEU THR LYS VAL HIS THR GLU CYS CYS HIS GLY ASP SEQRES 20 A 581 LEU LEU GLU CYS ALA ASP ASP ARG ALA ASP LEU ALA LYS SEQRES 21 A 581 TYR ILE CYS GLU ASN GLN ASP SER ILE SER SER LYS LEU SEQRES 22 A 581 LYS GLU CYS CYS GLU LYS PRO LEU LEU GLU LYS SER HIS SEQRES 23 A 581 CYS ILE ALA GLU VAL GLU ASN ASP GLU MET PRO ALA ASP SEQRES 24 A 581 LEU PRO SER LEU ALA ALA ASP PHE VAL GLU SER LYS ASP SEQRES 25 A 581 VAL CYS LYS ASN TYR ALA GLU ALA LYS ASP VAL PHE LEU SEQRES 26 A 581 GLY MET PHE LEU TYR GLU TYR ALA ARG ARG HIS PRO ASP SEQRES 27 A 581 TYR SER VAL VAL LEU LEU LEU ARG LEU ALA LYS THR TYR SEQRES 28 A 581 GLU THR THR LEU GLU LYS CYS CYS ALA ALA ALA ASP PRO SEQRES 29 A 581 HIS GLU CYS TYR ALA LYS VAL PHE ASP GLU PHE LYS PRO SEQRES 30 A 581 LEU VAL GLU GLU PRO GLN ASN LEU ILE LYS GLN ASN CYS SEQRES 31 A 581 GLU LEU PHE GLU GLN LEU GLY GLU TYR LYS PHE GLN ASN SEQRES 32 A 581 ALA LEU LEU VAL ARG TYR THR LYS LYS VAL PRO GLN VAL SEQRES 33 A 581 SER THR PRO THR LEU VAL GLU VAL SER ARG ASN LEU GLY SEQRES 34 A 581 LYS VAL GLY SER LYS CYS CYS LYS HIS PRO GLU ALA LYS SEQRES 35 A 581 ARG MET PRO CYS ALA GLU ASP TYR LEU SER VAL VAL LEU SEQRES 36 A 581 ASN GLN LEU CYS VAL LEU HIS GLU LYS THR PRO VAL SER SEQRES 37 A 581 ASP ARG VAL THR LYS CYS CYS THR GLU SER LEU VAL ASN SEQRES 38 A 581 ARG ARG PRO CYS PHE SER ALA LEU GLU VAL ASP GLU THR SEQRES 39 A 581 TYR VAL PRO LYS GLU PHE ASN ALA GLU THR PHE THR PHE SEQRES 40 A 581 HIS ALA ASP ILE CYS THR LEU SER GLU LYS GLU ARG GLN SEQRES 41 A 581 ILE LYS LYS GLN THR ALA LEU VAL GLU LEU VAL LYS HIS SEQRES 42 A 581 LYS PRO LYS ALA THR LYS GLU GLN LEU LYS ALA VAL MET SEQRES 43 A 581 ASP ASP PHE ALA ALA PHE VAL GLU LYS CYS CYS LYS ALA SEQRES 44 A 581 ASP ASP LYS GLU THR CYS PHE ALA GLU GLU GLY LYS LYS SEQRES 45 A 581 LEU VAL ALA ALA SER GLN ALA ALA LEU HET PLM A1001 13 HET PLM A1002 18 HET PLM A1003 17 HET PLM A1004 18 HET PLM A1005 17 HET PLM A1006 18 HET 7GE A1007 18 HET 7GE A1008 19 HETNAM PLM PALMITIC ACID HETNAM 7GE PENTAKIS(CHLORANYL)-(1~{H}-INDAZOL-2-IUM-2-YL) HETNAM 2 7GE RUTHENIUM(1-) FORMUL 2 PLM 6(C16 H32 O2) FORMUL 8 7GE 2(C7 H6 CL5 N2 RU) FORMUL 10 HOH *9(H2 O) HELIX 1 AA1 SER A 5 GLY A 15 1 11 HELIX 2 AA2 GLY A 15 LEU A 31 1 17 HELIX 3 AA3 PRO A 35 ASP A 56 1 22 HELIX 4 AA4 SER A 65 CYS A 75 1 11 HELIX 5 AA5 THR A 76 ALA A 78 5 3 HELIX 6 AA6 THR A 79 GLY A 85 1 7 HELIX 7 AA7 GLY A 85 CYS A 91 1 7 HELIX 8 AA8 PRO A 96 HIS A 105 1 10 HELIX 9 AA9 GLU A 119 ASN A 130 1 12 HELIX 10 AB1 ASN A 130 HIS A 146 1 17 HELIX 11 AB2 TYR A 150 CYS A 169 1 20 HELIX 12 AB3 ASP A 173 PHE A 206 1 34 HELIX 13 AB4 PHE A 206 PHE A 223 1 18 HELIX 14 AB5 GLU A 227 CYS A 246 1 20 HELIX 15 AB6 ASP A 249 ASN A 267 1 19 HELIX 16 AB7 PRO A 282 GLU A 292 1 11 HELIX 17 AB8 LEU A 305 VAL A 310 1 6 HELIX 18 AB9 ASP A 314 ALA A 322 1 9 HELIX 19 AC1 ALA A 322 HIS A 338 1 17 HELIX 20 AC2 SER A 342 CYS A 361 1 20 HELIX 21 AC3 PRO A 366 LEU A 398 1 33 HELIX 22 AC4 GLY A 399 VAL A 415 1 17 HELIX 23 AC5 SER A 419 CYS A 438 1 20 HELIX 24 AC6 PRO A 441 THR A 467 1 27 HELIX 25 AC7 SER A 470 GLU A 479 1 10 HELIX 26 AC8 ASN A 483 ALA A 490 1 8 HELIX 27 AC9 ALA A 504 THR A 508 5 5 HELIX 28 AD1 HIS A 510 THR A 515 5 6 HELIX 29 AD2 SER A 517 LYS A 536 1 20 HELIX 30 AD3 THR A 540 CYS A 559 1 20 HELIX 31 AD4 LYS A 564 LEU A 583 1 20 SSBOND 1 CYS A 53 CYS A 62 1555 1555 2.03 SSBOND 2 CYS A 75 CYS A 91 1555 1555 2.04 SSBOND 3 CYS A 90 CYS A 101 1555 1555 2.03 SSBOND 4 CYS A 124 CYS A 169 1555 1555 2.03 SSBOND 5 CYS A 168 CYS A 177 1555 1555 2.03 SSBOND 6 CYS A 200 CYS A 246 1555 1555 2.03 SSBOND 7 CYS A 245 CYS A 253 1555 1555 2.03 SSBOND 8 CYS A 265 CYS A 279 1555 1555 2.03 SSBOND 9 CYS A 278 CYS A 289 1555 1555 2.03 SSBOND 10 CYS A 316 CYS A 361 1555 1555 2.03 SSBOND 11 CYS A 360 CYS A 369 1555 1555 2.03 SSBOND 12 CYS A 392 CYS A 438 1555 1555 2.03 SSBOND 13 CYS A 437 CYS A 448 1555 1555 2.03 SSBOND 14 CYS A 461 CYS A 477 1555 1555 2.03 SSBOND 15 CYS A 476 CYS A 487 1555 1555 2.03 SSBOND 16 CYS A 514 CYS A 559 1555 1555 2.03 SSBOND 17 CYS A 558 CYS A 567 1555 1555 2.03 LINK NH2 ARG A 348 O1 PLM A1003 1555 1555 1.30 LINK NZ LYS A 351 O1 PLM A1006 1555 1555 1.30 LINK CB CYS A 360 SG CYS A 369 1555 1555 1.58 LINK SG CYS A 360 CB CYS A 369 1555 1555 1.92 LINK NE2 HIS A 146 RU2 7GE A1007 1555 1555 1.79 CISPEP 1 GLU A 95 PRO A 96 0 4.23 SITE 1 AC1 5 ARG A 117 TYR A 138 ALA A 158 TYR A 161 SITE 2 AC1 5 PHE A 165 SITE 1 AC2 8 VAL A 23 LEU A 66 LEU A 69 TYR A 150 SITE 2 AC2 8 ALA A 254 ARG A 257 LEU A 283 SER A 287 SITE 1 AC3 7 SER A 342 VAL A 344 ARG A 348 PRO A 384 SITE 2 AC3 7 LEU A 453 ARG A 485 PLM A1004 SITE 1 AC4 8 LEU A 387 TYR A 411 VAL A 418 LEU A 460 SITE 2 AC4 8 HIS A 464 ARG A 485 SER A 489 PLM A1003 SITE 1 AC5 9 TYR A 401 PHE A 507 LYS A 525 ALA A 528 SITE 2 AC5 9 LEU A 532 VAL A 547 PHE A 551 SER A 579 SITE 3 AC5 9 GLN A 580 SITE 1 AC6 4 ARG A 209 VAL A 216 ASP A 324 LYS A 351 SITE 1 AC7 4 HIS A 146 GLY A 189 LYS A 190 SER A 193 SITE 1 AC8 6 LYS A 199 ARG A 218 HIS A 242 SER A 287 SITE 2 AC8 6 ALA A 291 HOH A1109 CRYST1 185.845 38.710 96.070 90.00 105.12 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005381 0.000000 0.001454 0.00000 SCALE2 0.000000 0.025833 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010782 0.00000